unknown
Stage
1
Investors
About
Vivid Dx is developing a novel diagnostic platform for the early detection of cancer using liquid biopsy and circulating tumour DNA (ctDNA). The company aims to provide non-invasive and highly accurate cancer screening.
Explore Vivid Dx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.